Familial chylomicronemia syndrome is a rare inherited disease that prevents the body from breaking down lipids. Redemplo ...

Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA.

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.

New data quantify the long-term risk of second cancers post-breast cancer. Dr Maurie Markman explores 20-year outcomes and ...

Giving undue attention to an ‘important’ patient not only is unfair to others but also can negatively affect care.

Women with severe tricuspid regurgitation exhibit fewer comorbidities, less right ventricular remodelling, and significantly better long-term survival rates than men.

Satralizumab is safe and effective for patients with myelin oligodendrocyte glycoprotein antibody-associated disease, the new ...

Nearly all patients with primary biliary cholangitis receive ursodeoxycholic acid, but a substantial proportion are ...

Can definitive radiotherapy targeting the full ‘triangle’ space improve local disease control in patients with inoperable pancreatic cancer?

A new trend emerging in post-9/11 veterans shows that roughly half of this young adult group has hypertension, and more than ...

Newer pacing method matched standard cardiac resynchronization therapy with respect to clinical outcomes in the first ...